[{"Assets_0_Q1_USD":60561087.0,"EarningsPerShareBasic_1_Q1_USD":-0.04,"EarningsPerShareDiluted_1_Q1_USD":-0.04,"NetIncomeLoss_1_Q1_USD":-1366181.0,"StockholdersEquity_0_Q1_USD":35240027.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":30976140.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":30976140.0,"Ticker":"VERU","CIK":"863894","name":"FEMALE HEALTH CO","OfficialName":"Veru Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1011836411.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170209"}]